In addition, we show that Bmi1 over expression cannot substitute for p53 loss in a predisposing genetic model of medulloblastoma which indicates that the oncogenic function of Bmi1 is mediated by p16INK4A/Rb mediated effects rather then through p19ARF/p53 effects. The gene discussed is CDKN2A; the disease is medulloblastoma.